Ophthalmology Department, University Hospital of Larissa, Larissa, Greece.
Anaesthesiology Department, General State Hospital of Nikaia-Piraeus "St. Panteleimon", Athens, Greece.
Int Ophthalmol. 2024 Sep 2;44(1):362. doi: 10.1007/s10792-024-03259-7.
The treatment of unilateral amblyopia involves refractive adaptation, occlusion therapy or penalization with atropine drops. However, in recent years, the use of binocular digital therapy has shown promising results. Aim of this systematic review was to evaluate the effectiveness of binocular treatment of amblyopia compared with standard treatments or placebo therapy.
This systematic review was conducted in accordance to PRISMA statement. Electronic literature was thoroughly searched for articles published between 2013 and May 2024, in the following electronic database; Pubmed, CENTRAL, MedlinePlus, Medline Europe, PLOS, Scopus, Clinicaltrials.gov. The review comprised randomized control trials (RCTs) including patients with unilateral amblyopia, who received binocular therapy or standard amblyopia or placebo treatment for more than two weeks and who had visual acuity assessment pre- and post-treatment. Only articles written in English were included. Risk of bias was assessed with the Rob2 tool, while study quality was evaluated with the modified Jadad scale.
Twenty RCTs, including 1769 patients, were incorporated into this systematic review. Twelve different types of binocular amblyopia treatments were identified and categorized into two main types. The first type involves the presentation of low-contrast images in the fellow eye, including stimuli presented only in the amblyopic eye. The second type combines this approach with complementary dichoptic deficits in the images presented to both eyes to encourage their simultaneous use.
Binocular amblyopia treatment has shown promising results in addressing unilateral anisometropic, strabismic or mixed type of amblyopia. Nevertheless, further randomized controlled trials are essential to establish the exact dosage, type and duration of binocular therapy as a standard component of amblyopia care.
单侧弱视的治疗包括屈光矫正、遮盖疗法或阿托品滴眼剂压抑疗法。然而,近年来,双眼数字疗法的应用显示出了有前景的效果。本系统评价旨在评估双眼治疗弱视与标准治疗或安慰剂治疗相比的有效性。
本系统评价按照 PRISMA 声明进行。电子文献全面检索了 2013 年至 2024 年 5 月期间发表的文章,检索了以下电子数据库:PubMed、CENTRAL、MedlinePlus、Medline Europe、PLOS、Scopus、Clinicaltrials.gov。综述包括随机对照试验(RCT),纳入了单侧弱视患者,他们接受了双眼治疗或标准弱视或安慰剂治疗超过两周,且在治疗前后都进行了视力评估。仅纳入了以英语撰写的文章。使用 Rob2 工具评估偏倚风险,使用改良 Jadad 量表评估研究质量。
本系统评价纳入了 20 项 RCT,共 1769 名患者。确定了 12 种不同类型的双眼弱视治疗方法,并将其分为两种主要类型。第一种类型涉及在对侧眼呈现低对比度图像,包括仅在弱视眼中呈现的刺激。第二种类型结合了这种方法与双眼呈现的互补性视差缺陷,以鼓励同时使用双眼。
双眼弱视治疗在解决单侧屈光不正性、斜视性或混合性弱视方面显示出了有前景的效果。然而,仍需要进一步的随机对照试验来确定双眼治疗的确切剂量、类型和持续时间,作为弱视治疗的标准组成部分。